Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling-Reference-Cited by-同舟云学术

Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling

Published:2022-08 Issue:8 Volume:29 Page:1260-1272.e8
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Geng Chen-Lu,Chen Jun-Yi,Song Tian-Yu,Jung Jae Hyung,Long Min,Song Min-Fang,Ji Tong,Min Byung Soh^ORCID,Lee Jin Gu,Peng Bo,Pu Yi-Sheng,Fan Hong-Jie,Hao Piliang,Zhou Qi,Shin Eui-Cheol,Cang Yong^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference57 articles.

1. pSILAC mass spectrometry reveals ZFP91 as IMiD-dependent substrate of the CRL4(CRBN) ubiquitin ligase;An;Nat. Commun.,2017

2. Activation of Th1 immunity within the tumor microenvironment is associated with clinical response to lenalidomide in chronic lymphocytic leukemia;Aue;J. Immunol.,2018

3. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells;Bandyopadhyay;Blood,2007

4. The evolution of thalidomide and its IMiD derivatives as anticancer agents;Bartlett;Nat. Rev. Cancer,2004

5. Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report;Berg;J. Clin. Oncol.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets;Experimental Hematology & Oncology;2024-08-30

2. Targeting Ikaros and Aiolos: reviewing novel protein degraders for the treatment of multiple myeloma, with a focus on iberdomide and mezigdomide;Expert Review of Hematology;2024-07-27

3. Exploring the role of CD8⁺ T cells in clear renal cell carcinoma metastasis;FEBS Open Bio;2024-06-13

4. Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7;Leukemia;2023-12-20

5. Chimeric Antigen Receptor T Cells in Multiple Myeloma;Hematology/Oncology Clinics of North America;2023-12